Comparative Efficacy and Rapidity of Action for Infliximab vs. Ustekinumab in Biologic Naive Crohn’s Disease

Citation:

Narula N, Wong ECL, Dulai PS, et al. Clin Gastroenterol Hepatol. 2022 Jul;20(7):1579-1587.e2. Epub 2021 Apr 7. PMID: 33838348.